Sangamo BioSciences | Betriebsergebnis


Operating Profit Veränderung
Alnylam Pharmaceuticals ALNY:US $ -191.69M 44.95M
Amgen AMGN:US $ 2176M 324M
Avrobio Inc AVRO:US -27774000 1.64M
Bayer BAYN:GR 169M 4.04B
Biocryst Pharmaceuticals BCRX:US $ -34.72M 15.24M
Biogen BIIB:US $ -59.1M 669.8M
Biomarin Pharmaceutical BMRN:US $ 39.15M 98.18M
Bluebird Bio BLUE:US $ -107.4M 12.95M
Gilead Sciences GILD:US $ 2029M 1832M
GlaxoSmithKline GSK:LN 108.1B 121.2B
Intercept Pharmaceuticals ICPT:US $ -13.36M 3.09M
IONIS PHARMACEUT IONS:US $ -85.51M 28.01M
Johnson & Johnson JNJ:US $ 5840M 22M
Karyopharm Therapeutics KPTI:US $ -42908000 8.32M
Merk MRK:US $ 4927M 642M
Novartis NOVN:VX 2.23B 624M
Omeros OMER:US $ -37438000 2.39M
Pfizer PFE:US $ 12102M 2229M
Regulus Therapeutics RGLS:US $ -7.18M 0.61M
Sangamo Biosciences SGMO:US $ -45.73M 0.47M
Sarepta Therapeutics SRPT:US $ -211.13M 124.25M
Ultragenyx Pharmaceutical RARE:US $ -141.59M 4.96M
Vertex Pharmaceuticals VRTX:US $ 1106.3M 65.4M
Ziopharm Oncology ZIOP:US $ -9233000 148K



Sangamo BioSciences Betriebsergebnis - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Sep 2022.